A potential game-changer in Alzheimer’s treatment has emerged from UCLA Health, where scientists have identified a compound that can restore memory function in mice with symptoms of the disease. This groundbreaking discovery, centered around a molecule called DDL-920, could pave the way for a novel approach to treating Alzheimer’s that goes beyond merely slowing the disease’s progression. The study, published in The Proceedings of the National Academy of Sciences, demonstrated that DDL-920 effectively “jumpstarted” the brain’s memory circuitry. Alzheimer’s disease is a progressive neurological…